Skip to content
Disclosery

CITADEL ADVISORS LLC: TMED position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CITADEL ADVISORS LLC on TMED, newest first. How the timeline and the estimate are built.

CITADEL ADVISORS LLC held 5,958 TMED shares at 2026-06-30 per its 13F-HR/A filed 2026-09-02.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F/A 5,958 shares
    Change vs previous 13F -60,702 shares

    <0.01% of the 13F portfolio, value $203,482.

    13F-HR/A 0001104659-26-104387 filed by CITADEL ADVISORS LLC
    Accepted , ingested

  2. period ended2026-03-31
    13F 66,660 shares
    Change vs previous 13F +39,059 shares

    <0.01% of the 13F portfolio, value $1,928,360.

    13F-HR 0001104659-26-062477 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 27,601 shares
    Change vs previous 13F -2,173 shares

    <0.01% of the 13F portfolio, value $820,390.

    13F-HR 0001104659-26-016408 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 29,774 shares
    Change vs previous 13F +20,189 shares

    <0.01% of the 13F portfolio, value $794,341.

    13F-HR 0001104659-25-112514 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 9,585 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $237,859.

    13F-HR 0001104659-25-078555 filed by CITADEL ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).